Intelligence Unit
Special Reports
Special Events
Subscribe
Sponsored
Departments
- Leadership
- Finance
- Technology
- Physicians
- Community Hospitals
- Health Plans
- Marketing
- Quality
- Nursing
- HR
Follow Us
U.S. cost-saving policy forces new kidney transplant
New York Times, September 14, 2009
Although the government regularly pays $100,000 or more for kidney transplants, it stops paying for anti-rejection drugs after only 36 months. The healthcare bill moving through the House of Representatives includes a little-noticed provision that would reverse the policy, but it is not clear whether the Senate will follow suit. The 36-month limit is one of several reimbursement anomalies that many in Congress hope to cure.
Most Viewed
Most Emailed
- $6.4B Henry Ford, Beaumont Merger Failed on Cultural Hurdles
- Fortunately, Angelina Jolie Isn't On Medicare
- Don't Let Nurses Sink Your Bottom Line
- House Lawmakers Grill CMS Over Health Exchange Navigators
- How Chargemaster Data May Affect Hospital Revenue
- Hospitals Profit On Bloodstream Infections
- Primary Care Docs Average More Hospital Revenue Than Specialists
- Hospital Pricing Transparency a Marketing Game Changer
- Less Blood Testing for Some Surgeries Safe, Cost Effective
- ED Physicians Key to Half of Hospital Admissions
